NASDAQ:VIVE - Viveve Medical Stock Price, Forecast & News

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Viveve Medical Inc (NASDAQ:VIVE) announced its quarterly earnings results on Thursday, November, 7th. The company reported ($13.51) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($16.00) by $2.49. The company earned $1.05 million during the quarter. View Viveve Medical's Earnings History.

Viveve Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viveve Medical.

5 equities research analysts have issued twelve-month price objectives for Viveve Medical's shares. Their forecasts range from $0.20 to $6.00. On average, they anticipate Viveve Medical's stock price to reach $2.40 in the next twelve months. This suggests a possible upside of 128.6% from the stock's current price. View Analyst Price Targets for Viveve Medical.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Viveve Medical.

Media stories about VIVE stock have been trending somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Viveve Medical earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an impact on the stock's share price in the near future. View News Stories for Viveve Medical.

Viveve Medical saw a decline in short interest in the month of January. As of January 15th, there was short interest totalling 164,300 shares, a decline of 43.6% from the December 31st total of 291,500 shares. Based on an average daily volume of 1,420,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.1% of the company's stock are short sold. View Viveve Medical's Current Options Chain.

Some companies that are related to Viveve Medical include Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), Nexeon Medsystems (NXNN), Reshape Lifesciences (RSLS), CHF Solutions (CHFS), ReShape Lifesciences (RSLSD), Escalon Medical (ESMC), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Newcardio (NWCI), Echo Therapeutics (ECTE), 21st North (ULGX) and IMRIS (IMRSQ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Fortive (FTV), HP (HPQ), Lowe's Companies (LOW), Western Digital (WDC), SCYNEXIS (SCYX), Viking Therapeutics (VKTX), Trevena (TRVN) and Quantenna Communications (QTNA).

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VIVE stock can currently be purchased for approximately $1.05.

Viveve Medical has a market capitalization of $1.55 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($161.00) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.View Additional Information About Viveve Medical.

The official website for Viveve Medical is http://www.viveve.com/.

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]